Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 60 (HNRNPA1P60) is classified as a pseudogene in the human genome[1][7]. Unlike functional protein-coding genes, pseudogenes like HNRNPA1P60 do not encode active proteins and are not associated with direct biological roles, disease causation, or therapeutic targeting. The parent gene, HNRNPA1, encodes a member of the heterogeneous nuclear ribonucleoprotein (hnRNP) family, which are RNA-binding proteins involved in mRNA metabolism, particularly mRNA splicing and transport, and have documented relevance in neurodegenerative disease and cancers[2][4][5]. However, those functions do not extend to the pseudogene variant HNRNPA1P60, for which no specific biological function, disease involvement, or therapeutic significance has been reported[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 60 (HNRNPA1P60).